SERES THERAPEUTICS INC's ticker is MCRB and the CUSIP is 81750R102. A total of 121 filers reported holding SERES THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.63 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $89,000 | -58.6% | 13,937 | -77.8% | 0.00% | -66.7% |
Q2 2022 | $215,000 | -65.3% | 62,720 | -28.0% | 0.01% | -57.1% |
Q1 2022 | $620,000 | -15.8% | 87,067 | -1.4% | 0.01% | -17.6% |
Q4 2021 | $736,000 | +73.2% | 88,331 | +44.6% | 0.02% | +41.7% |
Q3 2021 | $425,000 | -69.4% | 61,097 | +5.0% | 0.01% | -73.3% |
Q2 2021 | $1,388,000 | +65.2% | 58,200 | +42.7% | 0.04% | +45.2% |
Q1 2021 | $840,000 | +94.9% | 40,795 | +167.8% | 0.03% | +19.2% |
Q3 2020 | $431,000 | +683.6% | 15,232 | +31.3% | 0.03% | +550.0% |
Q2 2020 | $55,000 | – | 11,600 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Flagship Pioneering Inc. | 23,117,045 | $110,730,646 | 4.94% |
Lion Point Capital, LP | 691,803 | $3,313,736 | 1.50% |
Eversept Partners, LP | 3,076,756 | $14,737,661 | 1.23% |
Soleus Capital Management, L.P. | 2,045,983 | $9,800,259 | 1.09% |
Knott David M Jr | 470,000 | $2,251 | 0.90% |
GREAT POINT PARTNERS LLC | 938,067 | $4,493,341 | 0.88% |
Simplify Asset Management Inc. | 550,626 | $2,637,499 | 0.35% |
Delphia (USA) Inc. | 33,913 | $162,443 | 0.26% |
Alpha DNA Investment Management LLC | 138,536 | $663,587 | 0.22% |
Avoro Capital Advisors LLC | 2,500,000 | $11,975,000 | 0.16% |